The Ministry of Popular Power for Health (MPPS) reported that the Venezuelan State Pharmaceutical Technology Conglomerate, Quimbiotec CA, after a Colombian-Venezuelan strategic alliance, begins the full recovery of its production areas of the blood derivatives plant.
This was indicated by the ministerial entity through its account on the social network Twitter, @MinSaludVEin which he also pointed out that with the investment the Venezuelan state company will be activated.
#308EfficientManagementDays the Colombian-Venezuelan strategic alliance began, for the activation, investment and total recovery of the productive areas of the Blood Products plant @QuimbiotecCA.#RebornHope#TogetherForEachHeartbeat@NicolasMaduro pic.twitter.com/DDhmtpWV2X
– MPPSalud (@MinSaludVE) December 25, 2022
It is worth noting that Quimbiotec CA is the only company that produces blood products in Venezuela. The national company produced, in 300 days of management, a batch containing 195 vials of the Hemin Arginate drug to treat liver diseases, according to an institutional press release.
In this way, the Venezuelan State remains in constant technological innovation to offer effective access to low, medium and high-end medicines.
VTV/FB/EMPG
